Cargando…

Immunotherapy of Mild Cognitive Impairment by ω-3 Supplementation: Why Are Amyloid-β Antibodies and ω-3 Not Working in Clinical Trials?

This article reviews the basic tenets of a clinical approach to effective immunotherapy of Alzheimer’s disease (AD) in patients with mild cognitive impairment (MCI). Although one randomized controlled study in early MCI patients by fish-derived omega-3 fatty acids (ω-3) showed slowing of disease pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiala, Milan, Restrepo, Lucas, Pellegrini, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870008/
https://www.ncbi.nlm.nih.gov/pubmed/29103035
http://dx.doi.org/10.3233/JAD-170579

Ejemplares similares